SlideShare ist ein Scribd-Unternehmen logo
1 von 46
Presentation By:
Christopher Khemraj
Mohamed Mohamed
Project Distribution By:
Ebey P. Soman

BETA-BLOCKERS
References
   Marks, Jay, and Omudhome Ogbru. "Beta Blockers." MedicineNet. MedicineNet, n.d. Web. 12 Nov 2010.
    <http://www.medicinenet.com/beta_blockers/article.htm>.
   "Beta-adrenergic Blocking Agents (Systemic)." Drugs.com. N.p., 20 OCT 2010. Web. 12 Nov 2010.
    <http://www.drugs.com/mmx/metoprolol-succinate.html>.
   "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc.
    . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
   "Medication Package Insert Information for: TENORMIN TABLET 50MG ." MEDSort. N.p., n.d. Web. 13 Nov 2010.
    <http://drugs.medsort.com/Drugs/DrugPackageInsert.aspx?MedID=5811#tablist>.
   Propranolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank
    (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~AGpJcu:1>.
   "Beta Blockers - Top 10 toxicities." University of Conneticut . Web. 14 Nov 2010.
    <http://www.uconnem.org/toxicologyweb/cardiovascular.jpg>.
   Atenolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank
    (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~SpU8BZ:1>.
   Heitz, Cory et al. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation
    Technology and Academic Research, n.d. Web. 15 Nov 2010.
    <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_-
    8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
   Sharma, Adhi. "Beta Blocker Toxicity." Emedicine from WebMD. WebMD, 03 NOV 2010. Web. 15 Nov 2010.
    <http://emedicine.medscape.com/article/813342-overview>.
   Rahm, Stephen. "A 4 year Old who ingested a medication." Pediatric Case Studies for the Paramedic. American
    Academic of Orthopaedic Surgeons, n.d. Web. 15 Nov 2010. <http://books.google.com/books?id=wO-
    5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>.
Quick Facts & Figures
 The 2007 Annual Report of            Of the fatalities reported to the
  the American Association of           AAPCC, 68% were associated
  Poison Control Centers' (AAPCC)       with individuals younger than 50
  National Poison Data                  years. Forty-three percent of all
  System reported 9291                  fatalities reported to the AAPCC
  single exposures to beta-             in 2004 were associated with
  blockers.                             children younger than 6 years.
 In 2007, the AAPCC reported 413      Propranolol is the most toxic
  minor outcomes, 631 moderate          beta-blocker because it is non-
  outcomes, 61 major outcomes,          selective and the most
  and 3 fatalities for beta-blocker     frequently used in suicide
  exposure                              attempts worldwide.
 According to the 2004 AAPCC
  toxic exposure review, 51% of all    Source: Sharma, Adhi. "Beta Blocker Toxicity."
                                       Emedicine from WebMD. WebMD, 03 NOV 2010. Web. 15
  exposures and 47.6% of all           Nov 2010.
  overdose fatalities are in women     <http://emedicine.medscape.com/article/813342-
                                       overview>.
So what are Beta-Blockers?
      Beta blockers are known as beta-adrenergic blocking
          agents and they block norepinephrine and epinephrine
          from binding to receptors on nerve cells.
         When norepinephrine and epinephrine are blocked, this
          reduces heart rate and lowers blood pressure by dilating
          the blood vessels.
         Beta blockers work mainly by blocking Beta 1 (heart,
          kidney, eyes) and Beta 2 receptors (lungs, liver, muscles
          etc.).
         Beta 3 is mostly in Adiposities and is blocked by
          nonselective beta blockers like propanolol
         There are tons of beta-blockers on the market and majority
          of these drugs used to treat cardiovascular diseases and
          glaucoma.
Source: Marks, Jay, and Omudhome Ogbru. "Beta Blockers." MedicineNet. MedicineNet, n.d. Web. 12 Nov 2010.
<http://www.medicinenet.com/beta_blockers/article.htm>.
Examples of Beta-Blockers (US)
    ACEBUTOLOL HYDROCHLORIDE                                      NEBIVOLOL
    ATENOLOL                                                      OXPRENOLOL
    BETAXOLOL HYDROCHLORIDE                                       PENBUTOLOL SULFATE
    BISOPROLOL FUMARATE                                           PINDOLOL
    LABETALOLCARTEOLOL                                            PROPRANOLOL HYDROCHLORIDE
     HYDROCHLORIDE                                                      PROPRANOLOL HYDROCHLORIDE
                                                                         INJECTION
    CARVEDILOL
                                                                        PROPRANOLOL HYDROCHLORIDE
    ESMOLOL HYDROCHLORIDE                                               ORAL
    METOPROLOL                                                    SOTALOL HYDROCHLORIDE
         METOPROLOL SUCCINATE ORAL                                     SOTALOL HYDROCHLORIDE
         METOPROLOL TARTRATE INJECTION                                  INJECTION
         METOPROLOL TARTRATE ORAL                                      SOTALOL HYDROCHLORIDE ORAL
    NADOLOL                                                       TIMOLOL MALEATE
                                                                   And many more exist, especially in
                                                                    foreign markets

Source: "Beta-adrenergic Blocking Agents (Systemic)." Drugs.com. N.p., 20 OCT 2010. Web. 12 Nov
2010. <http://www.drugs.com/mmx/metoprolol-succinate.html>.
FDA Approved Indications
   Hypertension
   Pediatric hypertensive emergency
   Angina pectoris
   Cardiac arrhythmias/tachycardias
   MI
   CHF
   Pheochromocytoma
   Migraine prevention
   Hypertrophic subaortic stenosis
   Parkinsonian tremors
   Akathisia
   Bleeding in portal hypertension
   Atrial fibrillation
   Generalized anxiety disorder       - Image Source: "Atenolol." 1aMeds. Web. 12 Nov
                                       2010.
   Angina                             <http://www.1ameds.net/images/Atenolol.jpg>.
                                       - Source: "Beta-Adrenergic Blocking Agents (Beta
   Thyrotoxicosis                     Blockers)." Facts and Comparisons 2010. n. pag.
   Fibromyalgia                       Wolters Kluwer Health, Inc. . Web. 12 Nov 2010.
                                       <http://online.factsandcomparisons.com>.
How do they Work?
      Beta-adrenergic receptor blocking
       agents compete with beta-adrenergic                                Above:
       agonists for available beta receptor sites.                        Propranolol
      Propranolol, nadolol, timolol,
       penbutolol, sotalol, and pindolol inhibit
       both the beta 1 receptors and the beta
       2receptors
      Metoprolol, acebutolol, bisoprolol,
       esmolol, betaxolol, and atenolol are
       more selective and inhibit beta -1
       receptors (heart mostly)

Sources:
"Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and
Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov
2010. <http://online.factsandcomparisons.com>.
"Atenolol Enantiomers Structural Formula." Wikipedia. Web. 12 Nov     The 2
2010. <http://en.wikipedia.org/wiki/File:%28%C2%B1%29-                Enantiomers
Atenolol_Enantiomers_Structural_Formulae.png>.
"Propranolol-2D-skeletal." Wikipedia. Web. 12 Nov 2010.               of Atenolol
<http://en.wikipedia.org/wiki/File:Propranolol-2D-skeletal.png>.
Pharmacokinetics

    Absorption                                                         Distribution
     Many beta blockers undergo                                        There is no simple
          first pass metabolism upon                                     relationship between dose
          ingestion.                                                     given, drug plasma levels and
                                                                         resulting therapeutic effect
     Only Pindolol and Sotalol                                          since response to a beta
          have no first pass effect                                      blocker is individual based
     Having food in the stomach                                        Metoprolol and propranolol
          decreases the absorption of                                    can cross the blood brain
          most beta blockers but                                         barrier so they can produce
          increases absorption of                                        CNS effects in overdose.
          metoprolol and propranolol.                                    Atenolol does not cross BBB
Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and     so less chances of CNS effects
Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010.
<http://online.factsandcomparisons.com>.
Pharmacokinetics (Con’t)

Metabolism                                            Excretion
 Majority of beta blockers                            Atenolol is 50% excreted
  are metabolized in the liver                  unchanged in feces
 Sotalol is not metabolized               Majority of beta blockers are
  but no data exists for the                    excreted through urine
  extend of Sotalol                        Sotalol is excreted
  absorption                                    unchanged into the urine
 As mentioned before,                     Only 30-40% of Acebutolol is
                                                excreted via renal tubules,
  many beta blockers
                                                the rest are excreted in the
  undergo first pass
                                                bile and other routes
  metabolism              Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and
                          Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010.
                                       <http://online.factsandcomparisons.com>.
Black Box Warnings (BBW)
For atenolol, metoprolol,                 For sotalol
nadolol, propranolol & timolol
 Abrupt stop in beta-                    Do not substitute sotalol
  blocker treatment may                    for sotalol AF
  worsen angina, give                     If patient has drug induced
  myocardial infarction and                arrhythmia then monitor
  ventricular arrythmias                   patient for 3 days in health
                                           care facility when starting
 If you are going to stop the             sotalol or sotalol AF
  treatment, then taper the                regimen
  dose                                    Cardiac resuscitation, ECG
 If angina occurs, restart                monitoring and renal
  beta blocker therapy                     monitoring is needed
                         Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and
                         Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010.
                         <http://online.factsandcomparisons.com>.
Pregnancy & Beta Blockers
   Mostly Category C but…
    Atenolol is category D
    Atenolol crosses the placental
         barrier
        Studies show mothers taking
         Atenolol from 2nd trimester had
         babies that were too small
        No studies on 1st trimester or
         any other fetal harm
        Only Category B drugs are
         acebutolol, pindolol & sotalol
        Most beta blockers are excreted                           So talk to your doctor if you have a little one
         in breast milk                                            on the way before taking beta blockers!
Sources: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. .
Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
"Pregnancy & Chiropractic." chiropracticatthecomo. Web. 13 Nov 2010.
<http://www.chiropracticatthecomo.com/Images/Pregnant.jpg>.
Signs & Symptoms of Overdose
Cardiac Issues                                       GI & Metabolic issues
 Asystole                                               Mesenteric ischemia
                                                         esophageal spasms
 Tachycardia
                                                         Hyperkalemia
 prolonged QT interval
                                                         hypoglycemia
    (sotalol)
   prolonged QRS complex
   ventricular dysrhythmias
   Hypotension
   hypertension (partial
    agonists)
   Bradycardia
   AV block
               Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag.
               Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
               "Prolonged QRS Complex." natomy & Physiology Note Summaries. Web. 13 Nov 2010.
               <http://legacy.owensboro.kctcs.edu/gcaplan/anat2/notes/Image347.gif>.
Signs & Symptoms (Con’t)

   CNS & Renal Issues                                               Respiratory Issues
    Seizures                                                        Apnea
    Coma or depressed level of                                      Cyanosis
     consciousness                                                   respiratory depression
    Renal failure                                                   bronchospasm




Source: Atenolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data
Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~SpU8BZ:1>.
"Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health,
Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
Exposure Risk Assessment

    Before treating patient , try to determine the
        following:
       Patient's age
       Past medical history or condition
       Name of product and strength (if possible)
       Time of overdose
       How much or what amount they swallowed
       Was it prescribed to the patient?
Source: Atenolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous
Substances Data Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-
bin/sis/search/f?./temp/~SpU8BZ:1>.
Time Frame of Exposure

 Symptoms may occur
  within 6 hours after
  ingestion and can be as
  quick as 20 minutes
 Onset of detectable
  symptoms will depend
  on formulations.
  Extended release          Source: Propranolol: Toxicology Data Network (TOXNET). National
                            Library of Medicine :Hazardous Substances Data Bank (HSDA), Web.
  formulations will take    15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-
                            bin/sis/search/f?./temp/~AGpJcu:1>.
  longer to manifest        "Beta Blockers - Top 10 toxicities." University of Conneticut . Web. 14
                            Nov 2010.
                            <http://www.uconnem.org/toxicologyweb/cardiovascular.jpg>.
Laboratory: What to monitor
 Vital Signs such Blood
    Pressure
   Mental Status: is the
    patient alert?
   ECG – Important to
    monitor for bradycardia,
    heart failure or other
    severe cardiac issues
   Serum electrolyte levels
    will be low
   Renal failure can occur
   Blood glucose levels will   Source: Propranolol: Toxicology Data Network (TOXNET). National
    drop significantly          Library of Medicine :Hazardous Substances Data Bank (HSDA), Web. 15
                                Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-
                                bin/sis/search/f?./temp/~AGpJcu:1>.
                                "Vital Signs Cartoons and Comics." CartoonStock. Web. 14 Nov 2010.
                                <http://www.cartoonstock.com/lowres/hsc0561l.jpg>.
Suggested Treatments

1-2 Hours after Ingestion
 Perform assessment of
  patient condition
 Determine serum glucose
  levels – if hypoglycemic, treat
  with IV glucagon
 Give activated charcoal to all
  patients and gastric lavage if
  still within the 2 hour period
 If is ER tablets they ingested,
  then do whole bowel
  irrigation with polyethylene
  glycol (PEG)
 Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health,
 Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
 "Polyethylene Glycol." Drugs.com. Web. 13 Nov 2010. <http://www.drugs.com/pro/polyethylene-glycol.html>.
Treatments (Con’t)
Supportive Treatments                                   Benzodiazepines for Seizures!

 chest radiography to
  prevent cardiac failure
 serum electrolytes to
  prevent potassium buildup
 Treat seizures with
  benzodiazepines, if they
  are not working, then treat
  with barbiturates
 Make sure activated
  charcoal is given Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n.
                                  pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010.
                                  <http://online.factsandcomparisons.com>.
                                  "Valium." Imageshack. Web. 13 Nov 2010.
                                  <http://img31.imageshack.us/img31/2313/valium2.jpg>.
Treatments (Con’t)

Last step therapy
 Atenolol, acebutolol, sotalol,
   and nadolol are the only beta
   blockers that can be removed
   by hemodialysis
 Treat bronchospasm with
   beta agonists like albuterol
 In patients who are still not
   responding to treatments
                                   Source: "Beta-Adrenergic Blocking Agents (Beta
   mentioned above,                Blockers)." Facts and Comparisons 2010. n. pag. Wolters
                                   Kluwer Health, Inc. . Web. 12 Nov 2010.
   epinephrine (parenteral) may    <http://online.factsandcomparisons.com>.
                                   "Epinephrine." MaineVille. Web. 13 Nov 2010.
   be needed                       <http://bdnimages.sprintout.com/uploads/large/127691247
                                   3_8d68.jpg>.
Other Treatment Options
 Catecholamine agents –                                            Atropine – Most commonly
  Epinephrine is most                                                used alternative agent but
  commonly used. However                                             least effective. If patient does
  isoproterenol and dopamine                                         not respond to a 1mg dose of
  can be used as well                                                atropine, you verify beta
 Phosphodiesterase inhibitors -                                     blocker toxicity (diagnosis
  Milrinone, aminophylline and                                       tool)
  theophylline. Amrinone has                                        Pacemakers – Control cardiac
  been shown to be good in                                           pace in severe beta blocker
  dog trials                                                         induced bradycardia
 Insulin – High doses                                              intra-aortic balloon pump – to
 Lipid Emulsion – IV, for                                           restore perfusion and blood
  propanolol overdose                                                flow

Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. .
Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
Atenolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), Web.
15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~SpU8BZ:1>.
Treatment Dosages
   IV fluids 500 mL boluses up                                 If patient has QRS
    to 2L to raise blood                                         widening and ventricular
    pressure if the patient is                                   dysrhythmias, then treat
    hypotensive                                                  with IV sodium bicarbonate
   1 to 2 mg lorazepam IV or                                    1 to 2 mEq/kg IV bolus
    another benzodiazepine                                       starting dose, titrate to
    for seizures                                                 blood pH 7.45 to 7.55
   Propofol can be used along                                  Use lidocaine if sodium
    with the lorazepam                                           bicarb is not working
                                                                Liquid Activated Charcoal:
                                                                 1 g/kg PO up to 50-100
Source: Propranolol: Toxicology Data Network (TOXNET).
National Library of Medicine :Hazardous Substances Data Bank     grams. For children up to
(HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-
bin/sis/search/f?./temp/~AGpJcu:1>.
                                                                 15-30 grams
Sharma, Adhi. "Beta Blocker Toxicity." Emedicine from WebMD.
WebMD, 03 NOV 2010. Web. 15 Nov 2010.
<http://emedicine.medscape.com/article/813342-overview>.
Treatment Dosages (Con’t)
   Glucagon: Initial dosing is 5 to 15 mg
    slow IV push with an infusion rate of
    5 to 15 mg/hour.
   Phosphodiesterase inhibitor
    (Inamrinone) - 1 mg/kg bolus then 3
    to 6 mcg/kg/minute
   Calcium for beta blocker
    (propranolol or atenolol) &
    verapamil overdose - calcium
    chloride 0.2 mL/kg or calcium
    gluconate 0.6 mL/kg intravenously
   Dextrose bolus is another option.
    Give to patient with blood glucose
    of less than 250 mg/dL
    - Adults: 25 to 50 mL dextrose 50%
     - Children: 0.25 g/kg dextrose 25%
                      Source: Propranolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous
                      Substances Data Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-
                      bin/sis/search/f?./temp/~AGpJcu:1>.
                      "Dextrose." Vetone Pharmaceuticals . Web. 15 Nov 2010.
                      <http://www.vetone.net/images/pharmaceuticals/dextrose.jpg>.
Case Study 1
       Chief Complaint: “weak and tired”
       Patient is a 65 year old previously healthy Caucasian male, who came to
        the ED today because he feels “weak all over”. Symptoms began 2 days
        ago.
       Vital Signs: Heart rate 49, Blood Pressure 90/60, Respiratory Rate 12,
        Pulse Oximetry 95% on room air, Temperature 96.9 degrees Fahrenheit
       Past Medical History: He has had two previous myocardial infarctions
        (with a stent placed in his right coronary artery 2 years ago), congestive
        heart failure with an ejection fraction of 40%, hypertension,
        hyperlipidemia, diabetes mellitus type II, osteoarthritis, depression.
       Medications and Allergies: Only provide medication list if specifically
        requested. Medications include aspirin, glipizide, furosemide,
        metoprolol, clopidogrel, simvastatin, sertraline. Allergy to penicillin
        (rash)
       Family and Social History: 40 pack-year history of smoking, occasional
        alcohol use, denies illicit drug use. His mother died of a stroke at 82.
Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology
and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_-
8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
Cast Study 1 (Con’t)
        History given by patient: The patient reports that
         symptoms began 2 days ago and have worsened.
        He feels dizzy and as if he’s going to pass out. He has had
         no syncope. The dizziness is worse when he goes from a
         sitting to standing position.
        Associated symptoms: The patient has intermittent chest
         pains, which are described as sharp, fleeting, substernal,
         and without radiation. He has no chest pain currently. He
         has had mild dyspnea on exertion, a persistent dry cough,
         and mild nausea. He denies vomiting, diaphoresis, and
         hemoptysis. He has had a decreased appetite for one week.
         He has had no recent surgery, and no history of cancer,
         deep venous thrombosis, or pulmonary embolism. He
         denies headache, neck pain, visual changes, abdominal
         pain, fevers, rashes, or change in his bowel movements.
Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology
and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_-
8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
Case Study 1 (Con’t)

   Initial Exam:
    Patient is a healthy appearing male. Patient is
      awake, alert, and oriented. Comfortable without
      distress. Appears slightly fatigued.
    Cardiovascular: Bradycardia with regular
      rhythm.
    Lungs: Scattered rhonchi and end-expiratory
      wheezes bilaterally, with no rales.
    All other physical examination results were
      normal however the patient got worse during
      the physical exam and condition deteriorated
Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology
and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_-
8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
Case Study 1 (Con’t)

    Lab Results:
   Sodium: 144, Chloride: 98, BUN: 36, Potassium
     4.5, Bicarb: 18, Creatinine 1.7, glucose 138
   Urinalysis: Normal
   INR: 1.0
   Plateletes 383, WBC 8.4, Hemoglobin 11.1,
     Hematocrit 34.0

Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology
and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_-
8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
Case Study 1 (Con’t)




     ECG Shows Bradycardia
Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology
and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_-
8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
Case Study 1 (Con’t)

     IV fluids can be administered in response to his
      worsening hypotension, but IV fluid alone will
      not correct his low blood pressure.
     None of the lab results are helpful in identifying
      beta blocker toxicity
     Atropine was given, but did not resolve the
      patient’s bradycardia due to severe toxicity
     Physician suspected beta blocker toxicity so
      administered glucagon which brought BP and
      heart rate back to normal – without continuous
      glucagon infusion, the BP and heart rate will
         began to fail again
Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology
and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_-
8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
Case Study 1 (Con’t)

     After multiple doses of glucagon failed to
      maintain the patient’s vital signs,
      vasopressors were initiated.
     Dopamine or norephinephrine was okay to
      use
     Glucagon infusion helped resolve bradycardia
     The patient was stabilized and given under
      the care of a cardiologist.
Source: Heitz, Cory, et al. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation
Technology and Academic Research, n.d. Web. 15 Nov 2010.
<http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_-
8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
Case Study 2
 EMS was called after a 4
  year old female child was
  found unconscious by her
  mother
 Child’s mother says the
  child accidently ingested
  her husband’s blood
  pressure medication and
  she does not know how
  many the child took
                                Source: Rahm, Stephen. "A 4 year Old who ingested a
 EMS identified the            medication." Pediatric Case Studies for the Paramedic.
  medication as Sectral SR      American Academic of Orthopaedic Surgeons, n.d. Web. 15
                                Nov 2010. <http://books.google.com/books?id=wO-
  which is a extended release   5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>.
  beta blocker                  "BabyTemperament." BabySleepSite. Web. 15 Nov 2010.
                                <http://www.babysleepsite.com/wp-
                                content/uploads/2009/06/BabyTemperament.jpg>.
Case Study 2 (Con’t)

       Initial Assessment:
        Child is 35 pounds or 16kg
        The Child is unconscious and unresponsive
        Rapid shallow respiratory rate
        Slow and weak pulse
        Skin is cool and cyanosis is noted
        Capillary refill time was 3 seconds
        Bilateral wheezing is heard in the lungs
        No trauma or injury or bleeding found
Source: Rahm, Stephen. "A 4 year Old who ingested a medication." Pediatric Case Studies for the Paramedic. American Academic of
Orthopaedic Surgeons, n.d. Web. 15 Nov 2010. <http://books.google.com/books?id=wO-
5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>.
Case Study 2 (Con’t)

Assessment Values:
 Blood glucose reading says her glucose level is
  40mg/dl
 Blood Pressure: 70/40 mm Hg
 Pulse: 66 beats/min
 Respiratory Rate: 48 breaths/min

                                                                          Child’s ECG
                                                                          reading shows
                                                                          bradycardia

Source: Rahm, Stephen. "A 4 year Old who ingested a medication." Pediatric Case Studies for the Paramedic.
American Academic of Orthopaedic Surgeons, n.d. Web. 15 Nov 2010. <http://books.google.com/books?id=wO-
5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>.
"bradycardiac." Emedicine. Web. 15 Nov 2010.
<http://img.medscape.com/pi/emed/ckb/emergency_medicine/756148-812410-813342-1371539.jpg>.
Case Study 2 (Con’t)

 Opened the child’s airway                           Glucagon 0.05-0.1 mg/kg
  and intubated the child                    IV up to 1mg dose. 1mg
 Ventilate with 100%                        dose is repeated every 20
  oxygen since RR is too low                 minutes to raise BP and
                                             heart rate
 Agonize beta 2 receptor
  sites via nebulizer solution           Monitored child to make
  of albuterol – this will                   sure child was responsive
  cause broncodilation                       to the glucagon.
 Albuterol dose was 10mg
  (2ml) diluted in 3ml of
  normal saline             Source: Rahm, Stephen. "A 4 year Old who ingested a medication."
                                        Pediatric Case Studies for the Paramedic. American Academic of
                                        Orthopaedic Surgeons, n.d. Web. 15 Nov 2010.
                                        <http://books.google.com/books?id=wO-
                                        5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>.
Case Study 3
 39-year-old man was found
  unresponsive with empty
  bottle of atenolol, and
  some empty beer bottles
 Patient’s color was pale
  and dusky
 EMS personnel initiated an
  intravenous line and
  administered 2 mg of
  naloxone, 100 mg of          Source: Slater, T. (2001). A 39-year-old man with an overdose
  thiamine, and one ampule     of beta-blockers. Journal Of Emergency Nursing: JEN: Official
  of d-glucose (D50W)          Publication Of The Emergency Department Nurses Association,
                               27(4), 323-326. Retrieved from MEDLINE database.
  intravenously without        Image Source: "Beta Blocker Overdose." Buzzle. Web. 15 Nov
                               2010. <http://www.buzzle.com/img/articleImages/438293-
  effect                       2623-34.jpg>.
Case Study 3 (Con’t)

 Assessment:
  respiratory rate was only 8 breaths per
   minute
  Pulse: 20 beats per minute
  Blood pressure: 74 mm Hg systolic
  Glasgow Coma Score was 7
  EKG showed underlying rhythm of sinus
   arrest
Source: Slater, T. (2001). A 39-year-old man with an overdose of beta-blockers. Journal Of
Emergency Nursing: JEN: Official Publication Of The Emergency Department Nurses
Association, 27(4), 323-326. Retrieved from MEDLINE database.
Case Study 3 (Con’t)

 Patient put on                                                   50g of activated
  ventilator with 100%                                              charcoal were
  oxygen 14 breaths per                                             administered via the
  minute                                                            nasogastric tube
 One mg of IV atropine                                            Gastric lavage showed
  was administered                                                  no pill fragments
  without effect                                                   Poison control center
 Patient put on external                                           was contacted for
  cardiac pacing of 70                                              further instructions
  beats per minute
Source: Slater, T. (2001). A 39-year-old man with an overdose of beta-blockers. Journal Of
Emergency Nursing: JEN: Official Publication Of The Emergency Department Nurses
Association, 27(4), 323-326. Retrieved from MEDLINE database.
Case Study 3 (Con’t)

  Poison control advised 12 mg of glucagon was
   given by IV bolus which raised BP to 80 mm Hg
   but heart rate was still low at 30 beats/min
  3 gm of calcium chloride were administered via Iv
   boluses
  An isoproterenol infusion was initiated at 5 μg
   per minute
  Patient’s BP and heart rate began to go down
   more, Poison Control was contact and told
   hospital to discontinue Isoproterenol infusion
Source: Slater, T. (2001). A 39-year-old man with an overdose of beta-blockers. Journal Of
Emergency Nursing: JEN: Official Publication Of The Emergency Department Nurses
Association, 27(4), 323-326. Retrieved from MEDLINE database.
Case Study 3 (Con’t)

After initial treatment                After lab work
 Since the patient was getting         Dopamine infusion was titrated up
                                         to 20 μg/kg/minute
  worse, a complete blood and
  toxicology workup was                 simultaneous infusion of
                                         norepinephrine was added to try
  ordered.                               to keep the patient’s systolic blood
 Everything was negative                pressure greater than 90mm Hg
  except for exception of a             A glucagon infusion was also
                                         added at a rate of 10 mg/h. The
  blood glucose level of 211             patient’s blood sugar level was
  mg/dL and a blood alcohol              checked every 4 hours
  level of 318 mg/dL.                   insulin was administered as
                                         needed to treat the hyperglycemia
 Metabolic acidosis was                 caused by the glucagon.
  discovered during the blood     Source: Slater, T. (2001). A 39-year-old man with an overdose of
  test as well                    beta-blockers. Journal Of Emergency Nursing: JEN: Official
                                  Publication Of The Emergency Department Nurses Association, 27(4),
                                  323-326. Retrieved from MEDLINE database.
Case Study 3 (Con’t)

 Investigation revealed the
   patient ingested 1500 to 2000
   mg of sustained-release atenolol
 Supportive care with continuous
   infusions of dopamine,
   norepinephrine, and glucagon,
   along with cardiac pacing,
   sustained the patient until the
   effects of the atenolol subsided.
                                       Source: Slater, T. (2001). A 39-year-old man with an overdose
 Approximately 26 hours after his     of beta-blockers. Journal Of Emergency Nursing: JEN: Official
                                       Publication Of The Emergency Department Nurses Association,
   overdose, this patient’s blood      27(4), 323-326. Retrieved from MEDLINE database.
                                       "Discharge From Hospital." Imagine.com. Web. 15 Nov 2010.
   pressure and heart rate             <http://images.inmagine.com/img/hana/hana023/hana023175
   stabilized and he was released      .jpg>.
Case Study 4

 16-year-old female
  presented to the ED
  approximately 1.5 h after
  ingesting 6.0 g of
  acebutolol (brand name
  Sectral) in a suicide
  attempt
 Patient was sleepy with
  “shallow respirations”
  and was complaining of      Source: Love, J. (2000). Acebutolol overdose resulting in
                              fatalities. The Journal Of Emergency Medicine, 18(3), 341-
  nausea.                     344. Retrieved from MEDLINE database.
                              "Coma Picture." Getty Images. Web. 15 Nov 2010.
 She had pale and cool       <http://images.mirror.co.uk/upl/m4/nov2009/9/3/coma-

  skin with low pulse         pic-getty-51293773.jpg>.
Case Study 4 (Con’t)

      Assessment Values                                                     Treatment
       No cyanosis and the lungs                                            Dopamine was begun at 5
           were clear                                                         mg/kg/min and titrated up
       Heart rate was 70 beats per                                           to 30 mg/kg/min with no
           minute                                                             effect
       Blood pressure was 114/87                                            glucagon (two 10-mg
           mmHg                                                               boluses), isoproterenol
       Within 10 min of arrival to ED,                                       (titrated to 9.0 mg/min),
           blood pressure dropped to                                          and calcium chloride (10
           55/45 mmHg while the pulse                                         mL of a 10% solution) were
           remained 70 bpm                                                    added without success
Source: Source: Love, J. (2000). Acebutolol overdose resulting in fatalities. The Journal Of
Emergency Medicine, 18(3), 341-344. Retrieved from MEDLINE database.
Case Study 4 (Con’t)

 Initial ECG showed PR =    Whenever ventricular
  0.200 seconds, QRS =        tachycardia occurred due
  0.167 seconds, QTc =        to QRS waves widening,
  0.574 seconds with 70       defibrillation and
  bpm for heart rate          lidocaine was used to
 1 Hour later, ECG           treat it with no effect
  showed heart rates at      The patient had one
  120 bpm with no P           seizure during this time
  waves.                      to defibrillations but not
 QRS waves widened to        reoccurring seizures
  0.200 seconds with
  bizarre variability        Source: Source: Love, J. (2000). Acebutolol overdose
                             resulting in fatalities. The Journal Of Emergency
                             Medicine, 18(3), 341-344. Retrieved from MEDLINE
                             database.
Case Study 4 (Con’t)

 Since the patient was not responding,
  epinephrine was given - 9 boluses of 1.0 mg
  followed by a infusion titrated to 25 mg/min
 Sodium bicarbonate given - 3 boluses at 1
  meq/kg)
 Charcoal was recommended by the Poison
  Control Center but never given
 Suddenly the patient with into bradycardia – she
  did not respond to atropine 3.0 mg and external
  cardiac pacing
 She was pronounced dead in the ED within 4 h of
  her ingestion.   Source: Source: Love, J. (2000). Acebutolol overdose resulting in fatalities. The
                   Journal Of Emergency Medicine, 18(3), 341-344. Retrieved from MEDLINE database.
Case Study 4 (Con’t)

What went wrong?                                                  So what does that all mean?
 The patient did not respond                                      Acetbutolol blocked beta
  to a number of therapies                                          receptors while blocking the
                                                                    sodium and potassium channels in
 Acebutolol is a partial agonist                                   the heart leading to ventricular
  and membrane-stabilizing                                          dysrhythmias being developed
  activity                                                         Due to significant ion imbalances
 This agent blocked sodium                                         in the heart, this is a complex
  channels which prolonged PR                                       tachycardia which lead to
                                                                    ventricular fibrillation – so the
  and QRS intervals                                                 patient crashed.
 In addition to this, Acebutolol                                  Acebutolol is one of the most toxic
  blocks potassium channels so                                      beta blockers when taken in an
  ventricular repolarization                                        overdose and has highest fatality
  time increases                                                    in beta blocker overdoses
  Source: Source: Love, J. (2000). Acebutolol overdose resulting in fatalities. The Journal Of
  Emergency Medicine, 18(3), 341-344. Retrieved from MEDLINE database.
Summary
   Propranolol is the most common beta-blocker involved in severe beta-blocker
    poisoning. It is nonselective and can lead to CNS depression, seizures, and
    prolongation of the QRS complex.
   Beta blocker toxicity is notably distinguished by bradycardia, low respiratory
    rate and hypoglycemia
   Seizures and other CNS effects can occur with beta blockers that can cross the
    blood brain barrier (more rarely with the other beta blockers)
   Overdoses of beta blockers with a combination of other drugs can have wide
    ranging systemic effects
   If within a short time after ingestion, give activated charcoal
   Treat with glucagon to raise blood glucose levels
   Widely used treatment is currently Atropine though it is considered less effective
   Treat bronchospasm with beta agonists like Albuterol
   Treat Seizures with Benzodiazepines like Valium
   If the patient is still unresponsive or the condition is still deteriorating, treat with
    epinephrine
Source: "Infant Feeding Myths." Mohav
County WIC. Web. 15 Nov 2010.
<http://legacy.co.mohave.az.us/WIC/image
s/theEnd.gif>.

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

NOAC( Novel Oral Anticoagulants) uses in the current era
NOAC( Novel Oral Anticoagulants) uses in the current eraNOAC( Novel Oral Anticoagulants) uses in the current era
NOAC( Novel Oral Anticoagulants) uses in the current era
 
Anti platelet therapy
Anti platelet therapyAnti platelet therapy
Anti platelet therapy
 
Newer anti platelet drugs
Newer anti platelet drugsNewer anti platelet drugs
Newer anti platelet drugs
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
 
Drugs altering ecg
Drugs altering ecgDrugs altering ecg
Drugs altering ecg
 
Beta receptor blockers
Beta receptor blockersBeta receptor blockers
Beta receptor blockers
 
Clinical approach to anticoagulation
Clinical approach to anticoagulationClinical approach to anticoagulation
Clinical approach to anticoagulation
 
Amiodarone, Drug of the month
Amiodarone, Drug of the monthAmiodarone, Drug of the month
Amiodarone, Drug of the month
 
Amiodarone
AmiodaroneAmiodarone
Amiodarone
 
N Acetylcysteine
N AcetylcysteineN Acetylcysteine
N Acetylcysteine
 
Anti platelet drugs
Anti platelet drugsAnti platelet drugs
Anti platelet drugs
 
Ivabradine review
Ivabradine reviewIvabradine review
Ivabradine review
 
Drugs in Heart Failure samia
Drugs  in Heart Failure  samiaDrugs  in Heart Failure  samia
Drugs in Heart Failure samia
 
Skeletal Muscle Relaxants
Skeletal Muscle RelaxantsSkeletal Muscle Relaxants
Skeletal Muscle Relaxants
 
AntiEpileptic Drugs
AntiEpileptic DrugsAntiEpileptic Drugs
AntiEpileptic Drugs
 
Management of hypertension in diabetes
Management of hypertension in diabetesManagement of hypertension in diabetes
Management of hypertension in diabetes
 
Inotropes and their choice
Inotropes and their choiceInotropes and their choice
Inotropes and their choice
 
Drug interactions of Heparin
Drug interactions of HeparinDrug interactions of Heparin
Drug interactions of Heparin
 
Acute poisoning of antidepressants
Acute poisoning of antidepressantsAcute poisoning of antidepressants
Acute poisoning of antidepressants
 
Antidepressants toxictiy
Antidepressants toxictiyAntidepressants toxictiy
Antidepressants toxictiy
 

Andere mochten auch

Atenolol Presentation Clin 210 50
Atenolol   Presentation Clin 210 50Atenolol   Presentation Clin 210 50
Atenolol Presentation Clin 210 50Dr.RAJEEV KASHYAP
 
Beta-blockers in cardiovascular diseases
Beta-blockers in cardiovascular diseasesBeta-blockers in cardiovascular diseases
Beta-blockers in cardiovascular diseasesKunal Mahajan
 
Launching Simposium PIT IDI Kota Bogor 2013
Launching Simposium PIT IDI Kota Bogor 2013Launching Simposium PIT IDI Kota Bogor 2013
Launching Simposium PIT IDI Kota Bogor 2013mataharitimoer MT
 
Beta adrenergic blockers
Beta adrenergic blockersBeta adrenergic blockers
Beta adrenergic blockersKarun Kumar
 
Dr. onn akbar ali heart specialist kpj kajang heart failure and beta blocker
Dr. onn akbar ali heart specialist kpj kajang   heart failure and beta blockerDr. onn akbar ali heart specialist kpj kajang   heart failure and beta blocker
Dr. onn akbar ali heart specialist kpj kajang heart failure and beta blockerOnn Akbar Ali MBBS ; FRACP; FCSANZ
 
Cardivascular drug by maghan das
Cardivascular drug by maghan dasCardivascular drug by maghan das
Cardivascular drug by maghan dasMaghan Das
 
Established uses of beta blockers
Established uses of beta blockersEstablished uses of beta blockers
Established uses of beta blockersRamachandra Barik
 
Beta blockers in cardiology practice
Beta blockers in cardiology practiceBeta blockers in cardiology practice
Beta blockers in cardiology practicescsinha
 
Beta blockers
Beta blockersBeta blockers
Beta blockersjmnations
 
Beta blockers and calcium channel blockers
Beta blockers and calcium channel blockersBeta blockers and calcium channel blockers
Beta blockers and calcium channel blockersUma Binoy
 
Cardiovascular system Pharmacology
Cardiovascular system PharmacologyCardiovascular system Pharmacology
Cardiovascular system Pharmacologymharun5
 
Adrenergic antagonists alpha and beta blockers
Adrenergic antagonists   alpha and beta blockersAdrenergic antagonists   alpha and beta blockers
Adrenergic antagonists alpha and beta blockersZulcaif Ahmad
 
Toxicology pgy 1+2 2013
Toxicology pgy 1+2 2013Toxicology pgy 1+2 2013
Toxicology pgy 1+2 2013chricres
 

Andere mochten auch (20)

Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Beta blockers
Beta blockers Beta blockers
Beta blockers
 
Atenolol Presentation Clin 210 50
Atenolol   Presentation Clin 210 50Atenolol   Presentation Clin 210 50
Atenolol Presentation Clin 210 50
 
Beta-blockers in cardiovascular diseases
Beta-blockers in cardiovascular diseasesBeta-blockers in cardiovascular diseases
Beta-blockers in cardiovascular diseases
 
ADRENERGIC BLOCKERS
ADRENERGIC BLOCKERSADRENERGIC BLOCKERS
ADRENERGIC BLOCKERS
 
Launching Simposium PIT IDI Kota Bogor 2013
Launching Simposium PIT IDI Kota Bogor 2013Launching Simposium PIT IDI Kota Bogor 2013
Launching Simposium PIT IDI Kota Bogor 2013
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Beta adrenergic blockers
Beta adrenergic blockersBeta adrenergic blockers
Beta adrenergic blockers
 
Beta blockers dr wan azizi
Beta blockers dr wan aziziBeta blockers dr wan azizi
Beta blockers dr wan azizi
 
Dr. onn akbar ali heart specialist kpj kajang heart failure and beta blocker
Dr. onn akbar ali heart specialist kpj kajang   heart failure and beta blockerDr. onn akbar ali heart specialist kpj kajang   heart failure and beta blocker
Dr. onn akbar ali heart specialist kpj kajang heart failure and beta blocker
 
Cardivascular drug by maghan das
Cardivascular drug by maghan dasCardivascular drug by maghan das
Cardivascular drug by maghan das
 
Established uses of beta blockers
Established uses of beta blockersEstablished uses of beta blockers
Established uses of beta blockers
 
Beta blockers in cardiology practice
Beta blockers in cardiology practiceBeta blockers in cardiology practice
Beta blockers in cardiology practice
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Beta blockers and calcium channel blockers
Beta blockers and calcium channel blockersBeta blockers and calcium channel blockers
Beta blockers and calcium channel blockers
 
Cardiovascular system Pharmacology
Cardiovascular system PharmacologyCardiovascular system Pharmacology
Cardiovascular system Pharmacology
 
ANTI HIPERTENSI
ANTI HIPERTENSIANTI HIPERTENSI
ANTI HIPERTENSI
 
Adrenergic antagonists alpha and beta blockers
Adrenergic antagonists   alpha and beta blockersAdrenergic antagonists   alpha and beta blockers
Adrenergic antagonists alpha and beta blockers
 
Toxicology pgy 1+2 2013
Toxicology pgy 1+2 2013Toxicology pgy 1+2 2013
Toxicology pgy 1+2 2013
 
Flumazenil
FlumazenilFlumazenil
Flumazenil
 

Ähnlich wie Beta Blocker Toxicity and Safety

Bsbt 522 paclitaxel-ppt 1chanderhash-asu2017010100041
Bsbt 522 paclitaxel-ppt 1chanderhash-asu2017010100041Bsbt 522 paclitaxel-ppt 1chanderhash-asu2017010100041
Bsbt 522 paclitaxel-ppt 1chanderhash-asu2017010100041chanderhash kumar
 
Botulinum toxin in Urology
Botulinum toxin in UrologyBotulinum toxin in Urology
Botulinum toxin in UrologyApollo Hospitals
 
Evaluation of beta-blockers in Iraqi hospitals
Evaluation of beta-blockers in Iraqi hospitalsEvaluation of beta-blockers in Iraqi hospitals
Evaluation of beta-blockers in Iraqi hospitalsAlaa Fadhel Hassan Alwazni
 
Beta blockers
Beta blockers Beta blockers
Beta blockers M A Hasnat
 
Research Presentation: Alcoholism and Antidepressant Metabolism
Research Presentation: Alcoholism and Antidepressant MetabolismResearch Presentation: Alcoholism and Antidepressant Metabolism
Research Presentation: Alcoholism and Antidepressant Metabolismkeijello
 
"Killer Drugs & The Supplement Hall of Fame" - IMMH Brazil, 2015
"Killer Drugs & The Supplement Hall of Fame" - IMMH Brazil, 2015"Killer Drugs & The Supplement Hall of Fame" - IMMH Brazil, 2015
"Killer Drugs & The Supplement Hall of Fame" - IMMH Brazil, 2015Louis Cady, MD
 
Pharm Drug Paper Caitlyn Cloy
Pharm Drug Paper Caitlyn CloyPharm Drug Paper Caitlyn Cloy
Pharm Drug Paper Caitlyn CloyCaitlyn Cloy
 
Week 6 Alcohol antagonists
Week 6 Alcohol antagonistsWeek 6 Alcohol antagonists
Week 6 Alcohol antagonistsUbaldo Niña
 
Adrenergic antagonists
Adrenergic antagonistsAdrenergic antagonists
Adrenergic antagonistskencha swathi
 
Metoprolol (ellen soyombo) final
Metoprolol (ellen soyombo) finalMetoprolol (ellen soyombo) final
Metoprolol (ellen soyombo) finalesoyombo
 
Pambio Brochure 20160526
Pambio Brochure 20160526Pambio Brochure 20160526
Pambio Brochure 20160526Amos Ofer
 

Ähnlich wie Beta Blocker Toxicity and Safety (20)

Bsbt 522 paclitaxel-ppt 1chanderhash-asu2017010100041
Bsbt 522 paclitaxel-ppt 1chanderhash-asu2017010100041Bsbt 522 paclitaxel-ppt 1chanderhash-asu2017010100041
Bsbt 522 paclitaxel-ppt 1chanderhash-asu2017010100041
 
Botulinum toxin in Urology
Botulinum toxin in UrologyBotulinum toxin in Urology
Botulinum toxin in Urology
 
Bronchoconstrictor Drugs
Bronchoconstrictor Drugs Bronchoconstrictor Drugs
Bronchoconstrictor Drugs
 
Evaluation of beta-blockers in Iraqi hospitals
Evaluation of beta-blockers in Iraqi hospitalsEvaluation of beta-blockers in Iraqi hospitals
Evaluation of beta-blockers in Iraqi hospitals
 
IVMS-CNS Depressants II /Drugs of Abuse IV-Ethanol
IVMS-CNS Depressants II /Drugs of Abuse IV-Ethanol IVMS-CNS Depressants II /Drugs of Abuse IV-Ethanol
IVMS-CNS Depressants II /Drugs of Abuse IV-Ethanol
 
Bisoprolol
BisoprololBisoprolol
Bisoprolol
 
Paroxtine
ParoxtineParoxtine
Paroxtine
 
Beta blockers
Beta blockers Beta blockers
Beta blockers
 
Research Presentation: Alcoholism and Antidepressant Metabolism
Research Presentation: Alcoholism and Antidepressant MetabolismResearch Presentation: Alcoholism and Antidepressant Metabolism
Research Presentation: Alcoholism and Antidepressant Metabolism
 
"Killer Drugs & The Supplement Hall of Fame" - IMMH Brazil, 2015
"Killer Drugs & The Supplement Hall of Fame" - IMMH Brazil, 2015"Killer Drugs & The Supplement Hall of Fame" - IMMH Brazil, 2015
"Killer Drugs & The Supplement Hall of Fame" - IMMH Brazil, 2015
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Pharm Drug Paper Caitlyn Cloy
Pharm Drug Paper Caitlyn CloyPharm Drug Paper Caitlyn Cloy
Pharm Drug Paper Caitlyn Cloy
 
Drug Safety Alert 5 Ketoconazole
Drug Safety Alert 5 KetoconazoleDrug Safety Alert 5 Ketoconazole
Drug Safety Alert 5 Ketoconazole
 
Week 6 Alcohol antagonists
Week 6 Alcohol antagonistsWeek 6 Alcohol antagonists
Week 6 Alcohol antagonists
 
Adrenergic antagonists
Adrenergic antagonistsAdrenergic antagonists
Adrenergic antagonists
 
Metoprolol (ellen soyombo) final
Metoprolol (ellen soyombo) finalMetoprolol (ellen soyombo) final
Metoprolol (ellen soyombo) final
 
Beta adrenergic receptor blockers
Beta adrenergic receptor blockersBeta adrenergic receptor blockers
Beta adrenergic receptor blockers
 
Pambio Brochure 20160526
Pambio Brochure 20160526Pambio Brochure 20160526
Pambio Brochure 20160526
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 

Beta Blocker Toxicity and Safety

  • 1. Presentation By: Christopher Khemraj Mohamed Mohamed Project Distribution By: Ebey P. Soman BETA-BLOCKERS
  • 2. References  Marks, Jay, and Omudhome Ogbru. "Beta Blockers." MedicineNet. MedicineNet, n.d. Web. 12 Nov 2010. <http://www.medicinenet.com/beta_blockers/article.htm>.  "Beta-adrenergic Blocking Agents (Systemic)." Drugs.com. N.p., 20 OCT 2010. Web. 12 Nov 2010. <http://www.drugs.com/mmx/metoprolol-succinate.html>.  "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.  "Medication Package Insert Information for: TENORMIN TABLET 50MG ." MEDSort. N.p., n.d. Web. 13 Nov 2010. <http://drugs.medsort.com/Drugs/DrugPackageInsert.aspx?MedID=5811#tablist>.  Propranolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~AGpJcu:1>.  "Beta Blockers - Top 10 toxicities." University of Conneticut . Web. 14 Nov 2010. <http://www.uconnem.org/toxicologyweb/cardiovascular.jpg>.  Atenolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~SpU8BZ:1>.  Heitz, Cory et al. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_- 8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.  Sharma, Adhi. "Beta Blocker Toxicity." Emedicine from WebMD. WebMD, 03 NOV 2010. Web. 15 Nov 2010. <http://emedicine.medscape.com/article/813342-overview>.  Rahm, Stephen. "A 4 year Old who ingested a medication." Pediatric Case Studies for the Paramedic. American Academic of Orthopaedic Surgeons, n.d. Web. 15 Nov 2010. <http://books.google.com/books?id=wO- 5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>.
  • 3. Quick Facts & Figures  The 2007 Annual Report of  Of the fatalities reported to the the American Association of AAPCC, 68% were associated Poison Control Centers' (AAPCC) with individuals younger than 50 National Poison Data years. Forty-three percent of all System reported 9291 fatalities reported to the AAPCC single exposures to beta- in 2004 were associated with blockers. children younger than 6 years.  In 2007, the AAPCC reported 413  Propranolol is the most toxic minor outcomes, 631 moderate beta-blocker because it is non- outcomes, 61 major outcomes, selective and the most and 3 fatalities for beta-blocker frequently used in suicide exposure attempts worldwide.  According to the 2004 AAPCC toxic exposure review, 51% of all Source: Sharma, Adhi. "Beta Blocker Toxicity." Emedicine from WebMD. WebMD, 03 NOV 2010. Web. 15 exposures and 47.6% of all Nov 2010. overdose fatalities are in women <http://emedicine.medscape.com/article/813342- overview>.
  • 4. So what are Beta-Blockers?  Beta blockers are known as beta-adrenergic blocking agents and they block norepinephrine and epinephrine from binding to receptors on nerve cells.  When norepinephrine and epinephrine are blocked, this reduces heart rate and lowers blood pressure by dilating the blood vessels.  Beta blockers work mainly by blocking Beta 1 (heart, kidney, eyes) and Beta 2 receptors (lungs, liver, muscles etc.).  Beta 3 is mostly in Adiposities and is blocked by nonselective beta blockers like propanolol  There are tons of beta-blockers on the market and majority of these drugs used to treat cardiovascular diseases and glaucoma. Source: Marks, Jay, and Omudhome Ogbru. "Beta Blockers." MedicineNet. MedicineNet, n.d. Web. 12 Nov 2010. <http://www.medicinenet.com/beta_blockers/article.htm>.
  • 5. Examples of Beta-Blockers (US)  ACEBUTOLOL HYDROCHLORIDE  NEBIVOLOL  ATENOLOL  OXPRENOLOL  BETAXOLOL HYDROCHLORIDE  PENBUTOLOL SULFATE  BISOPROLOL FUMARATE  PINDOLOL  LABETALOLCARTEOLOL  PROPRANOLOL HYDROCHLORIDE HYDROCHLORIDE  PROPRANOLOL HYDROCHLORIDE INJECTION  CARVEDILOL  PROPRANOLOL HYDROCHLORIDE  ESMOLOL HYDROCHLORIDE ORAL  METOPROLOL  SOTALOL HYDROCHLORIDE  METOPROLOL SUCCINATE ORAL  SOTALOL HYDROCHLORIDE  METOPROLOL TARTRATE INJECTION INJECTION  METOPROLOL TARTRATE ORAL  SOTALOL HYDROCHLORIDE ORAL  NADOLOL  TIMOLOL MALEATE  And many more exist, especially in foreign markets Source: "Beta-adrenergic Blocking Agents (Systemic)." Drugs.com. N.p., 20 OCT 2010. Web. 12 Nov 2010. <http://www.drugs.com/mmx/metoprolol-succinate.html>.
  • 6. FDA Approved Indications  Hypertension  Pediatric hypertensive emergency  Angina pectoris  Cardiac arrhythmias/tachycardias  MI  CHF  Pheochromocytoma  Migraine prevention  Hypertrophic subaortic stenosis  Parkinsonian tremors  Akathisia  Bleeding in portal hypertension  Atrial fibrillation  Generalized anxiety disorder - Image Source: "Atenolol." 1aMeds. Web. 12 Nov 2010.  Angina <http://www.1ameds.net/images/Atenolol.jpg>. - Source: "Beta-Adrenergic Blocking Agents (Beta  Thyrotoxicosis Blockers)." Facts and Comparisons 2010. n. pag.  Fibromyalgia Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
  • 7. How do they Work?  Beta-adrenergic receptor blocking agents compete with beta-adrenergic Above: agonists for available beta receptor sites. Propranolol  Propranolol, nadolol, timolol, penbutolol, sotalol, and pindolol inhibit both the beta 1 receptors and the beta 2receptors  Metoprolol, acebutolol, bisoprolol, esmolol, betaxolol, and atenolol are more selective and inhibit beta -1 receptors (heart mostly) Sources: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>. "Atenolol Enantiomers Structural Formula." Wikipedia. Web. 12 Nov The 2 2010. <http://en.wikipedia.org/wiki/File:%28%C2%B1%29- Enantiomers Atenolol_Enantiomers_Structural_Formulae.png>. "Propranolol-2D-skeletal." Wikipedia. Web. 12 Nov 2010. of Atenolol <http://en.wikipedia.org/wiki/File:Propranolol-2D-skeletal.png>.
  • 8. Pharmacokinetics Absorption Distribution  Many beta blockers undergo  There is no simple first pass metabolism upon relationship between dose ingestion. given, drug plasma levels and resulting therapeutic effect  Only Pindolol and Sotalol since response to a beta have no first pass effect blocker is individual based  Having food in the stomach  Metoprolol and propranolol decreases the absorption of can cross the blood brain most beta blockers but barrier so they can produce increases absorption of CNS effects in overdose. metoprolol and propranolol. Atenolol does not cross BBB Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and so less chances of CNS effects Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
  • 9. Pharmacokinetics (Con’t) Metabolism Excretion  Majority of beta blockers  Atenolol is 50% excreted are metabolized in the liver unchanged in feces  Sotalol is not metabolized  Majority of beta blockers are but no data exists for the excreted through urine extend of Sotalol  Sotalol is excreted absorption unchanged into the urine  As mentioned before,  Only 30-40% of Acebutolol is excreted via renal tubules, many beta blockers the rest are excreted in the undergo first pass bile and other routes metabolism Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
  • 10. Black Box Warnings (BBW) For atenolol, metoprolol, For sotalol nadolol, propranolol & timolol  Abrupt stop in beta-  Do not substitute sotalol blocker treatment may for sotalol AF worsen angina, give  If patient has drug induced myocardial infarction and arrhythmia then monitor ventricular arrythmias patient for 3 days in health care facility when starting  If you are going to stop the sotalol or sotalol AF treatment, then taper the regimen dose  Cardiac resuscitation, ECG  If angina occurs, restart monitoring and renal beta blocker therapy monitoring is needed Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
  • 11. Pregnancy & Beta Blockers Mostly Category C but…  Atenolol is category D  Atenolol crosses the placental barrier  Studies show mothers taking Atenolol from 2nd trimester had babies that were too small  No studies on 1st trimester or any other fetal harm  Only Category B drugs are acebutolol, pindolol & sotalol  Most beta blockers are excreted So talk to your doctor if you have a little one in breast milk on the way before taking beta blockers! Sources: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>. "Pregnancy & Chiropractic." chiropracticatthecomo. Web. 13 Nov 2010. <http://www.chiropracticatthecomo.com/Images/Pregnant.jpg>.
  • 12. Signs & Symptoms of Overdose Cardiac Issues GI & Metabolic issues  Asystole  Mesenteric ischemia  esophageal spasms  Tachycardia  Hyperkalemia  prolonged QT interval  hypoglycemia (sotalol)  prolonged QRS complex  ventricular dysrhythmias  Hypotension  hypertension (partial agonists)  Bradycardia  AV block Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>. "Prolonged QRS Complex." natomy & Physiology Note Summaries. Web. 13 Nov 2010. <http://legacy.owensboro.kctcs.edu/gcaplan/anat2/notes/Image347.gif>.
  • 13. Signs & Symptoms (Con’t) CNS & Renal Issues Respiratory Issues  Seizures  Apnea  Coma or depressed level of  Cyanosis consciousness  respiratory depression  Renal failure  bronchospasm Source: Atenolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~SpU8BZ:1>. "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>.
  • 14. Exposure Risk Assessment  Before treating patient , try to determine the following:  Patient's age  Past medical history or condition  Name of product and strength (if possible)  Time of overdose  How much or what amount they swallowed  Was it prescribed to the patient? Source: Atenolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi- bin/sis/search/f?./temp/~SpU8BZ:1>.
  • 15. Time Frame of Exposure  Symptoms may occur within 6 hours after ingestion and can be as quick as 20 minutes  Onset of detectable symptoms will depend on formulations. Extended release Source: Propranolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), Web. formulations will take 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi- bin/sis/search/f?./temp/~AGpJcu:1>. longer to manifest "Beta Blockers - Top 10 toxicities." University of Conneticut . Web. 14 Nov 2010. <http://www.uconnem.org/toxicologyweb/cardiovascular.jpg>.
  • 16. Laboratory: What to monitor  Vital Signs such Blood Pressure  Mental Status: is the patient alert?  ECG – Important to monitor for bradycardia, heart failure or other severe cardiac issues  Serum electrolyte levels will be low  Renal failure can occur  Blood glucose levels will Source: Propranolol: Toxicology Data Network (TOXNET). National drop significantly Library of Medicine :Hazardous Substances Data Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi- bin/sis/search/f?./temp/~AGpJcu:1>. "Vital Signs Cartoons and Comics." CartoonStock. Web. 14 Nov 2010. <http://www.cartoonstock.com/lowres/hsc0561l.jpg>.
  • 17. Suggested Treatments 1-2 Hours after Ingestion  Perform assessment of patient condition  Determine serum glucose levels – if hypoglycemic, treat with IV glucagon  Give activated charcoal to all patients and gastric lavage if still within the 2 hour period  If is ER tablets they ingested, then do whole bowel irrigation with polyethylene glycol (PEG) Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>. "Polyethylene Glycol." Drugs.com. Web. 13 Nov 2010. <http://www.drugs.com/pro/polyethylene-glycol.html>.
  • 18. Treatments (Con’t) Supportive Treatments Benzodiazepines for Seizures!  chest radiography to prevent cardiac failure  serum electrolytes to prevent potassium buildup  Treat seizures with benzodiazepines, if they are not working, then treat with barbiturates  Make sure activated charcoal is given Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>. "Valium." Imageshack. Web. 13 Nov 2010. <http://img31.imageshack.us/img31/2313/valium2.jpg>.
  • 19. Treatments (Con’t) Last step therapy  Atenolol, acebutolol, sotalol, and nadolol are the only beta blockers that can be removed by hemodialysis  Treat bronchospasm with beta agonists like albuterol  In patients who are still not responding to treatments Source: "Beta-Adrenergic Blocking Agents (Beta mentioned above, Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. epinephrine (parenteral) may <http://online.factsandcomparisons.com>. "Epinephrine." MaineVille. Web. 13 Nov 2010. be needed <http://bdnimages.sprintout.com/uploads/large/127691247 3_8d68.jpg>.
  • 20. Other Treatment Options  Catecholamine agents –  Atropine – Most commonly Epinephrine is most used alternative agent but commonly used. However least effective. If patient does isoproterenol and dopamine not respond to a 1mg dose of can be used as well atropine, you verify beta  Phosphodiesterase inhibitors - blocker toxicity (diagnosis Milrinone, aminophylline and tool) theophylline. Amrinone has  Pacemakers – Control cardiac been shown to be good in pace in severe beta blocker dog trials induced bradycardia  Insulin – High doses  intra-aortic balloon pump – to  Lipid Emulsion – IV, for restore perfusion and blood propanolol overdose flow Source: "Beta-Adrenergic Blocking Agents (Beta Blockers)." Facts and Comparisons 2010. n. pag. Wolters Kluwer Health, Inc. . Web. 12 Nov 2010. <http://online.factsandcomparisons.com>. Atenolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~SpU8BZ:1>.
  • 21. Treatment Dosages  IV fluids 500 mL boluses up  If patient has QRS to 2L to raise blood widening and ventricular pressure if the patient is dysrhythmias, then treat hypotensive with IV sodium bicarbonate  1 to 2 mg lorazepam IV or 1 to 2 mEq/kg IV bolus another benzodiazepine starting dose, titrate to for seizures blood pH 7.45 to 7.55  Propofol can be used along  Use lidocaine if sodium with the lorazepam bicarb is not working  Liquid Activated Charcoal: 1 g/kg PO up to 50-100 Source: Propranolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank grams. For children up to (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi- bin/sis/search/f?./temp/~AGpJcu:1>. 15-30 grams Sharma, Adhi. "Beta Blocker Toxicity." Emedicine from WebMD. WebMD, 03 NOV 2010. Web. 15 Nov 2010. <http://emedicine.medscape.com/article/813342-overview>.
  • 22. Treatment Dosages (Con’t)  Glucagon: Initial dosing is 5 to 15 mg slow IV push with an infusion rate of 5 to 15 mg/hour.  Phosphodiesterase inhibitor (Inamrinone) - 1 mg/kg bolus then 3 to 6 mcg/kg/minute  Calcium for beta blocker (propranolol or atenolol) & verapamil overdose - calcium chloride 0.2 mL/kg or calcium gluconate 0.6 mL/kg intravenously  Dextrose bolus is another option. Give to patient with blood glucose of less than 250 mg/dL - Adults: 25 to 50 mL dextrose 50% - Children: 0.25 g/kg dextrose 25% Source: Propranolol: Toxicology Data Network (TOXNET). National Library of Medicine :Hazardous Substances Data Bank (HSDA), Web. 15 Nov. 2010. <http://toxnet.nlm.nih.gov/cgi- bin/sis/search/f?./temp/~AGpJcu:1>. "Dextrose." Vetone Pharmaceuticals . Web. 15 Nov 2010. <http://www.vetone.net/images/pharmaceuticals/dextrose.jpg>.
  • 23. Case Study 1  Chief Complaint: “weak and tired”  Patient is a 65 year old previously healthy Caucasian male, who came to the ED today because he feels “weak all over”. Symptoms began 2 days ago.  Vital Signs: Heart rate 49, Blood Pressure 90/60, Respiratory Rate 12, Pulse Oximetry 95% on room air, Temperature 96.9 degrees Fahrenheit  Past Medical History: He has had two previous myocardial infarctions (with a stent placed in his right coronary artery 2 years ago), congestive heart failure with an ejection fraction of 40%, hypertension, hyperlipidemia, diabetes mellitus type II, osteoarthritis, depression.  Medications and Allergies: Only provide medication list if specifically requested. Medications include aspirin, glipizide, furosemide, metoprolol, clopidogrel, simvastatin, sertraline. Allergy to penicillin (rash)  Family and Social History: 40 pack-year history of smoking, occasional alcohol use, denies illicit drug use. His mother died of a stroke at 82. Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_- 8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
  • 24. Cast Study 1 (Con’t)  History given by patient: The patient reports that symptoms began 2 days ago and have worsened.  He feels dizzy and as if he’s going to pass out. He has had no syncope. The dizziness is worse when he goes from a sitting to standing position.  Associated symptoms: The patient has intermittent chest pains, which are described as sharp, fleeting, substernal, and without radiation. He has no chest pain currently. He has had mild dyspnea on exertion, a persistent dry cough, and mild nausea. He denies vomiting, diaphoresis, and hemoptysis. He has had a decreased appetite for one week. He has had no recent surgery, and no history of cancer, deep venous thrombosis, or pulmonary embolism. He denies headache, neck pain, visual changes, abdominal pain, fevers, rashes, or change in his bowel movements. Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_- 8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
  • 25. Case Study 1 (Con’t) Initial Exam:  Patient is a healthy appearing male. Patient is awake, alert, and oriented. Comfortable without distress. Appears slightly fatigued.  Cardiovascular: Bradycardia with regular rhythm.  Lungs: Scattered rhonchi and end-expiratory wheezes bilaterally, with no rales.  All other physical examination results were normal however the patient got worse during the physical exam and condition deteriorated Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_- 8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
  • 26. Case Study 1 (Con’t)  Lab Results: Sodium: 144, Chloride: 98, BUN: 36, Potassium 4.5, Bicarb: 18, Creatinine 1.7, glucose 138 Urinalysis: Normal INR: 1.0 Plateletes 383, WBC 8.4, Hemoglobin 11.1, Hematocrit 34.0 Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_- 8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
  • 27. Case Study 1 (Con’t) ECG Shows Bradycardia Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_- 8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
  • 28. Case Study 1 (Con’t)  IV fluids can be administered in response to his worsening hypotension, but IV fluid alone will not correct his low blood pressure.  None of the lab results are helpful in identifying beta blocker toxicity  Atropine was given, but did not resolve the patient’s bradycardia due to severe toxicity  Physician suspected beta blocker toxicity so administered glucagon which brought BP and heart rate back to normal – without continuous glucagon infusion, the BP and heart rate will began to fail again Source: Heitz, Cory. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_- 8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
  • 29. Case Study 1 (Con’t)  After multiple doses of glucagon failed to maintain the patient’s vital signs, vasopressors were initiated.  Dopamine or norephinephrine was okay to use  Glucagon infusion helped resolve bradycardia  The patient was stabilized and given under the care of a cardiologist. Source: Heitz, Cory, et al. "BETA BLOCKER OVERDOSE." Emergency Medicine Education Online. Center for Simulation Technology and Academic Research, n.d. Web. 15 Nov 2010. <http://www.emedu.org/simlibrary/UploadFolder/152.11.191.200_- 8589677563690905358Beta%20Blocker%20Overdose%20FINAL.pdf>.
  • 30. Case Study 2  EMS was called after a 4 year old female child was found unconscious by her mother  Child’s mother says the child accidently ingested her husband’s blood pressure medication and she does not know how many the child took Source: Rahm, Stephen. "A 4 year Old who ingested a  EMS identified the medication." Pediatric Case Studies for the Paramedic. medication as Sectral SR American Academic of Orthopaedic Surgeons, n.d. Web. 15 Nov 2010. <http://books.google.com/books?id=wO- which is a extended release 5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>. beta blocker "BabyTemperament." BabySleepSite. Web. 15 Nov 2010. <http://www.babysleepsite.com/wp- content/uploads/2009/06/BabyTemperament.jpg>.
  • 31. Case Study 2 (Con’t) Initial Assessment:  Child is 35 pounds or 16kg  The Child is unconscious and unresponsive  Rapid shallow respiratory rate  Slow and weak pulse  Skin is cool and cyanosis is noted  Capillary refill time was 3 seconds  Bilateral wheezing is heard in the lungs  No trauma or injury or bleeding found Source: Rahm, Stephen. "A 4 year Old who ingested a medication." Pediatric Case Studies for the Paramedic. American Academic of Orthopaedic Surgeons, n.d. Web. 15 Nov 2010. <http://books.google.com/books?id=wO- 5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>.
  • 32. Case Study 2 (Con’t) Assessment Values:  Blood glucose reading says her glucose level is 40mg/dl  Blood Pressure: 70/40 mm Hg  Pulse: 66 beats/min  Respiratory Rate: 48 breaths/min Child’s ECG reading shows bradycardia Source: Rahm, Stephen. "A 4 year Old who ingested a medication." Pediatric Case Studies for the Paramedic. American Academic of Orthopaedic Surgeons, n.d. Web. 15 Nov 2010. <http://books.google.com/books?id=wO- 5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>. "bradycardiac." Emedicine. Web. 15 Nov 2010. <http://img.medscape.com/pi/emed/ckb/emergency_medicine/756148-812410-813342-1371539.jpg>.
  • 33. Case Study 2 (Con’t)  Opened the child’s airway  Glucagon 0.05-0.1 mg/kg and intubated the child IV up to 1mg dose. 1mg  Ventilate with 100% dose is repeated every 20 oxygen since RR is too low minutes to raise BP and heart rate  Agonize beta 2 receptor sites via nebulizer solution  Monitored child to make of albuterol – this will sure child was responsive cause broncodilation to the glucagon.  Albuterol dose was 10mg (2ml) diluted in 3ml of normal saline Source: Rahm, Stephen. "A 4 year Old who ingested a medication." Pediatric Case Studies for the Paramedic. American Academic of Orthopaedic Surgeons, n.d. Web. 15 Nov 2010. <http://books.google.com/books?id=wO- 5_8KqO94C&lpg=PP1&pg=PA65#v=onepage&q&f=false>.
  • 34. Case Study 3  39-year-old man was found unresponsive with empty bottle of atenolol, and some empty beer bottles  Patient’s color was pale and dusky  EMS personnel initiated an intravenous line and administered 2 mg of naloxone, 100 mg of Source: Slater, T. (2001). A 39-year-old man with an overdose thiamine, and one ampule of beta-blockers. Journal Of Emergency Nursing: JEN: Official of d-glucose (D50W) Publication Of The Emergency Department Nurses Association, 27(4), 323-326. Retrieved from MEDLINE database. intravenously without Image Source: "Beta Blocker Overdose." Buzzle. Web. 15 Nov 2010. <http://www.buzzle.com/img/articleImages/438293- effect 2623-34.jpg>.
  • 35. Case Study 3 (Con’t) Assessment:  respiratory rate was only 8 breaths per minute  Pulse: 20 beats per minute  Blood pressure: 74 mm Hg systolic  Glasgow Coma Score was 7  EKG showed underlying rhythm of sinus arrest Source: Slater, T. (2001). A 39-year-old man with an overdose of beta-blockers. Journal Of Emergency Nursing: JEN: Official Publication Of The Emergency Department Nurses Association, 27(4), 323-326. Retrieved from MEDLINE database.
  • 36. Case Study 3 (Con’t)  Patient put on  50g of activated ventilator with 100% charcoal were oxygen 14 breaths per administered via the minute nasogastric tube  One mg of IV atropine  Gastric lavage showed was administered no pill fragments without effect  Poison control center  Patient put on external was contacted for cardiac pacing of 70 further instructions beats per minute Source: Slater, T. (2001). A 39-year-old man with an overdose of beta-blockers. Journal Of Emergency Nursing: JEN: Official Publication Of The Emergency Department Nurses Association, 27(4), 323-326. Retrieved from MEDLINE database.
  • 37. Case Study 3 (Con’t)  Poison control advised 12 mg of glucagon was given by IV bolus which raised BP to 80 mm Hg but heart rate was still low at 30 beats/min  3 gm of calcium chloride were administered via Iv boluses  An isoproterenol infusion was initiated at 5 μg per minute  Patient’s BP and heart rate began to go down more, Poison Control was contact and told hospital to discontinue Isoproterenol infusion Source: Slater, T. (2001). A 39-year-old man with an overdose of beta-blockers. Journal Of Emergency Nursing: JEN: Official Publication Of The Emergency Department Nurses Association, 27(4), 323-326. Retrieved from MEDLINE database.
  • 38. Case Study 3 (Con’t) After initial treatment After lab work  Since the patient was getting  Dopamine infusion was titrated up to 20 μg/kg/minute worse, a complete blood and toxicology workup was  simultaneous infusion of norepinephrine was added to try ordered. to keep the patient’s systolic blood  Everything was negative pressure greater than 90mm Hg except for exception of a  A glucagon infusion was also added at a rate of 10 mg/h. The blood glucose level of 211 patient’s blood sugar level was mg/dL and a blood alcohol checked every 4 hours level of 318 mg/dL.  insulin was administered as needed to treat the hyperglycemia  Metabolic acidosis was caused by the glucagon. discovered during the blood Source: Slater, T. (2001). A 39-year-old man with an overdose of test as well beta-blockers. Journal Of Emergency Nursing: JEN: Official Publication Of The Emergency Department Nurses Association, 27(4), 323-326. Retrieved from MEDLINE database.
  • 39. Case Study 3 (Con’t)  Investigation revealed the patient ingested 1500 to 2000 mg of sustained-release atenolol  Supportive care with continuous infusions of dopamine, norepinephrine, and glucagon, along with cardiac pacing, sustained the patient until the effects of the atenolol subsided. Source: Slater, T. (2001). A 39-year-old man with an overdose  Approximately 26 hours after his of beta-blockers. Journal Of Emergency Nursing: JEN: Official Publication Of The Emergency Department Nurses Association, overdose, this patient’s blood 27(4), 323-326. Retrieved from MEDLINE database. "Discharge From Hospital." Imagine.com. Web. 15 Nov 2010. pressure and heart rate <http://images.inmagine.com/img/hana/hana023/hana023175 stabilized and he was released .jpg>.
  • 40. Case Study 4  16-year-old female presented to the ED approximately 1.5 h after ingesting 6.0 g of acebutolol (brand name Sectral) in a suicide attempt  Patient was sleepy with “shallow respirations” and was complaining of Source: Love, J. (2000). Acebutolol overdose resulting in fatalities. The Journal Of Emergency Medicine, 18(3), 341- nausea. 344. Retrieved from MEDLINE database. "Coma Picture." Getty Images. Web. 15 Nov 2010.  She had pale and cool <http://images.mirror.co.uk/upl/m4/nov2009/9/3/coma- skin with low pulse pic-getty-51293773.jpg>.
  • 41. Case Study 4 (Con’t) Assessment Values Treatment  No cyanosis and the lungs  Dopamine was begun at 5 were clear mg/kg/min and titrated up  Heart rate was 70 beats per to 30 mg/kg/min with no minute effect  Blood pressure was 114/87  glucagon (two 10-mg mmHg boluses), isoproterenol  Within 10 min of arrival to ED, (titrated to 9.0 mg/min), blood pressure dropped to and calcium chloride (10 55/45 mmHg while the pulse mL of a 10% solution) were remained 70 bpm added without success Source: Source: Love, J. (2000). Acebutolol overdose resulting in fatalities. The Journal Of Emergency Medicine, 18(3), 341-344. Retrieved from MEDLINE database.
  • 42. Case Study 4 (Con’t)  Initial ECG showed PR =  Whenever ventricular 0.200 seconds, QRS = tachycardia occurred due 0.167 seconds, QTc = to QRS waves widening, 0.574 seconds with 70 defibrillation and bpm for heart rate lidocaine was used to  1 Hour later, ECG treat it with no effect showed heart rates at  The patient had one 120 bpm with no P seizure during this time waves. to defibrillations but not  QRS waves widened to reoccurring seizures 0.200 seconds with bizarre variability Source: Source: Love, J. (2000). Acebutolol overdose resulting in fatalities. The Journal Of Emergency Medicine, 18(3), 341-344. Retrieved from MEDLINE database.
  • 43. Case Study 4 (Con’t)  Since the patient was not responding, epinephrine was given - 9 boluses of 1.0 mg followed by a infusion titrated to 25 mg/min  Sodium bicarbonate given - 3 boluses at 1 meq/kg)  Charcoal was recommended by the Poison Control Center but never given  Suddenly the patient with into bradycardia – she did not respond to atropine 3.0 mg and external cardiac pacing  She was pronounced dead in the ED within 4 h of her ingestion. Source: Source: Love, J. (2000). Acebutolol overdose resulting in fatalities. The Journal Of Emergency Medicine, 18(3), 341-344. Retrieved from MEDLINE database.
  • 44. Case Study 4 (Con’t) What went wrong? So what does that all mean?  The patient did not respond  Acetbutolol blocked beta to a number of therapies receptors while blocking the sodium and potassium channels in  Acebutolol is a partial agonist the heart leading to ventricular and membrane-stabilizing dysrhythmias being developed activity  Due to significant ion imbalances  This agent blocked sodium in the heart, this is a complex channels which prolonged PR tachycardia which lead to ventricular fibrillation – so the and QRS intervals patient crashed.  In addition to this, Acebutolol  Acebutolol is one of the most toxic blocks potassium channels so beta blockers when taken in an ventricular repolarization overdose and has highest fatality time increases in beta blocker overdoses Source: Source: Love, J. (2000). Acebutolol overdose resulting in fatalities. The Journal Of Emergency Medicine, 18(3), 341-344. Retrieved from MEDLINE database.
  • 45. Summary  Propranolol is the most common beta-blocker involved in severe beta-blocker poisoning. It is nonselective and can lead to CNS depression, seizures, and prolongation of the QRS complex.  Beta blocker toxicity is notably distinguished by bradycardia, low respiratory rate and hypoglycemia  Seizures and other CNS effects can occur with beta blockers that can cross the blood brain barrier (more rarely with the other beta blockers)  Overdoses of beta blockers with a combination of other drugs can have wide ranging systemic effects  If within a short time after ingestion, give activated charcoal  Treat with glucagon to raise blood glucose levels  Widely used treatment is currently Atropine though it is considered less effective  Treat bronchospasm with beta agonists like Albuterol  Treat Seizures with Benzodiazepines like Valium  If the patient is still unresponsive or the condition is still deteriorating, treat with epinephrine
  • 46. Source: "Infant Feeding Myths." Mohav County WIC. Web. 15 Nov 2010. <http://legacy.co.mohave.az.us/WIC/image s/theEnd.gif>.